Skip to main content
. Author manuscript; available in PMC: 2018 Mar 20.
Published in final edited form as: Eur Cell Mater. 2017 Mar 20;33:227–239. doi: 10.22203/eCM.v033a14

Fig. 6.

Fig. 6

Differences in the activation of canonical vs. non-canonical Smad pathways for MSCs within the CG scaffold in response to CTS. Relative phosphorylation of (A) the non-canonical Smad 2/3 and (B) the canonical Smad 1/5/8 at day 1 and 6 as determined by immunoblot. Data are represented as mean ± SEM (n = 3). b Significantly higher expression (p < 0.05) than static group at same day.